Real-World Data on Apatinib Efficacy - Results of a Retrospective Study in Metastatic Breast Cancer Patients Pretreated With Multiline Treatment

OBJECTIVES: The NCCN guidelines recommend that the addition of bevacizumab should be considered in metastatic breast cancers in some circumstances, but there are no recommendations for the similar antiangiogenic drug apatinib. The aim of this study was to evaluate the safety and efficacy of apatinib...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Zhaoyun, Shan, Jing, Yu, Qian, Wang, Xinzhao, Song, Xiang, Wang, Fukai, Li, Chao, Yu, Zhiyong, Yu, Jinming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8224527/
https://www.ncbi.nlm.nih.gov/pubmed/34178630
http://dx.doi.org/10.3389/fonc.2021.643654

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8224527/
https://www.ncbi.nlm.nih.gov/pubmed/34178630
http://dx.doi.org/10.3389/fonc.2021.643654

Ejemplares similares